IBDEI0NX ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10645,0)
 ;;=H43.822^^74^687^25
 ;;^UTILITY(U,$J,358.3,10645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10645,1,3,0)
 ;;=3^Vitreomacular Adhesion,Left Eye
 ;;^UTILITY(U,$J,358.3,10645,1,4,0)
 ;;=4^H43.822
 ;;^UTILITY(U,$J,358.3,10645,2)
 ;;=^5005958
 ;;^UTILITY(U,$J,358.3,10646,0)
 ;;=H35.711^^74^687^26
 ;;^UTILITY(U,$J,358.3,10646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10646,1,3,0)
 ;;=3^Central Serous Retinopathy,Right Eye
 ;;^UTILITY(U,$J,358.3,10646,1,4,0)
 ;;=4^H35.711
 ;;^UTILITY(U,$J,358.3,10646,2)
 ;;=^5005703
 ;;^UTILITY(U,$J,358.3,10647,0)
 ;;=H35.712^^74^687^27
 ;;^UTILITY(U,$J,358.3,10647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10647,1,3,0)
 ;;=3^Central Serous Retinopathy,Left Eye
 ;;^UTILITY(U,$J,358.3,10647,1,4,0)
 ;;=4^H35.712
 ;;^UTILITY(U,$J,358.3,10647,2)
 ;;=^5005704
 ;;^UTILITY(U,$J,358.3,10648,0)
 ;;=H35.383^^74^687^32
 ;;^UTILITY(U,$J,358.3,10648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10648,1,3,0)
 ;;=3^Toxic Maculopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,10648,1,4,0)
 ;;=4^H35.383
 ;;^UTILITY(U,$J,358.3,10648,2)
 ;;=^5005668
 ;;^UTILITY(U,$J,358.3,10649,0)
 ;;=H31.021^^74^687^34
 ;;^UTILITY(U,$J,358.3,10649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10649,1,3,0)
 ;;=3^Solar Retinopathy,Right Eye
 ;;^UTILITY(U,$J,358.3,10649,1,4,0)
 ;;=4^H31.021
 ;;^UTILITY(U,$J,358.3,10649,2)
 ;;=^5005443
 ;;^UTILITY(U,$J,358.3,10650,0)
 ;;=H31.022^^74^687^35
 ;;^UTILITY(U,$J,358.3,10650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10650,1,3,0)
 ;;=3^Solar Retinopathy,Left Eye
 ;;^UTILITY(U,$J,358.3,10650,1,4,0)
 ;;=4^H31.022
 ;;^UTILITY(U,$J,358.3,10650,2)
 ;;=^5005444
 ;;^UTILITY(U,$J,358.3,10651,0)
 ;;=H44.23^^74^687^36
 ;;^UTILITY(U,$J,358.3,10651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10651,1,3,0)
 ;;=3^Degenerative Myopia,Bilateral
 ;;^UTILITY(U,$J,358.3,10651,1,4,0)
 ;;=4^H44.23
 ;;^UTILITY(U,$J,358.3,10651,2)
 ;;=^5005989
 ;;^UTILITY(U,$J,358.3,10652,0)
 ;;=H31.011^^74^687^41
 ;;^UTILITY(U,$J,358.3,10652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10652,1,3,0)
 ;;=3^Macula Scars of Posterior Pole,Right Eye
 ;;^UTILITY(U,$J,358.3,10652,1,4,0)
 ;;=4^H31.011
 ;;^UTILITY(U,$J,358.3,10652,2)
 ;;=^5005439
 ;;^UTILITY(U,$J,358.3,10653,0)
 ;;=H31.012^^74^687^42
 ;;^UTILITY(U,$J,358.3,10653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10653,1,3,0)
 ;;=3^Macula Scars of Posterior Pole,Left Eye
 ;;^UTILITY(U,$J,358.3,10653,1,4,0)
 ;;=4^H31.012
 ;;^UTILITY(U,$J,358.3,10653,2)
 ;;=^5005440
 ;;^UTILITY(U,$J,358.3,10654,0)
 ;;=H35.50^^74^687^43
 ;;^UTILITY(U,$J,358.3,10654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10654,1,3,0)
 ;;=3^Retinal Dystrophy,Hereditary,Unspec
 ;;^UTILITY(U,$J,358.3,10654,1,4,0)
 ;;=4^H35.50
 ;;^UTILITY(U,$J,358.3,10654,2)
 ;;=^5005695
 ;;^UTILITY(U,$J,358.3,10655,0)
 ;;=H35.3110^^74^687^1
 ;;^UTILITY(U,$J,358.3,10655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10655,1,3,0)
 ;;=3^Non-Exudative ARMD,Right Eye (Unspec Stage)
 ;;^UTILITY(U,$J,358.3,10655,1,4,0)
 ;;=4^H35.3110
 ;;^UTILITY(U,$J,358.3,10655,2)
 ;;=^5138500
 ;;^UTILITY(U,$J,358.3,10656,0)
 ;;=H35.3120^^74^687^2
 ;;^UTILITY(U,$J,358.3,10656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10656,1,3,0)
 ;;=3^Non-Exudative ARMD,Left Eye (Unspec Stage)
 ;;^UTILITY(U,$J,358.3,10656,1,4,0)
 ;;=4^H35.3120
 ;;^UTILITY(U,$J,358.3,10656,2)
 ;;=^5138505
 ;;^UTILITY(U,$J,358.3,10657,0)
 ;;=H35.3210^^74^687^7
